ondansetron

Generic: ondansetron

Labeler: hf acquisition co llc, dba healthfirst
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name ondansetron
Generic Name ondansetron
Labeler hf acquisition co llc, dba healthfirst
Dosage Form TABLET, ORALLY DISINTEGRATING
Routes
ORAL
Active Ingredients

ondansetron 4 mg/1

Manufacturer
HF Acquisition Co LLC, DBA HealthFirst

Identifiers & Regulatory

Product NDC 51662-1514
Product ID 51662-1514_0f95632b-9d9d-3b6a-e063-6294a90a6bd9
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA090469
Listing Expiration 2026-12-31
Marketing Start 2020-03-31

Pharmacologic Class

Established (EPC)
serotonin-3 receptor antagonist [epc]
Mechanism of Action
serotonin 3 receptor antagonists [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 516621514
Hyphenated Format 51662-1514

Supplemental Identifiers

RxCUI
104894
UPC
0357237077108
UNII
4AF302ESOS
NUI
N0000175817 N0000175818

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name ondansetron (source: ndc)
Generic Name ondansetron (source: ndc)
Application Number ANDA090469 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 4 mg/1
source: ndc
Packaging
  • 2 BLISTER PACK in 1 BAG (51662-1514-1) / 2 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK
  • 2 BLISTER PACK in 1 BAG (51662-1514-2) / 1 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK
source: ndc

Packages (2)

51662-1514-1 2 BLISTER PACK in 1 BAG (51662-1514-1) / 2 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK 51662-1514-2 2 BLISTER PACK in 1 BAG (51662-1514-2) / 1 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK

Ingredients (1)

ondansetron (4 mg/1)

Linked Drug Pages (1)

ONDANSETRON ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "0f95632b-9d9d-3b6a-e063-6294a90a6bd9", "openfda": {"nui": ["N0000175817", "N0000175818"], "upc": ["0357237077108"], "unii": ["4AF302ESOS"], "rxcui": ["104894"], "spl_set_id": ["a22a94bc-4fa7-8a4e-e053-2a95a90a6308"], "pharm_class_epc": ["Serotonin-3 Receptor Antagonist [EPC]"], "pharm_class_moa": ["Serotonin 3 Receptor Antagonists [MoA]"], "manufacturer_name": ["HF Acquisition Co LLC, DBA HealthFirst"]}, "finished": true, "packaging": [{"sample": false, "description": "2 BLISTER PACK in 1 BAG (51662-1514-1)  / 2 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK", "package_ndc": "51662-1514-1", "marketing_start_date": "20200331"}, {"sample": false, "description": "2 BLISTER PACK in 1 BAG (51662-1514-2)  / 1 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK", "package_ndc": "51662-1514-2", "marketing_start_date": "20200331"}], "brand_name": "ONDANSETRON", "product_id": "51662-1514_0f95632b-9d9d-3b6a-e063-6294a90a6bd9", "dosage_form": "TABLET, ORALLY DISINTEGRATING", "pharm_class": ["Serotonin 3 Receptor Antagonists [MoA]", "Serotonin-3 Receptor Antagonist [EPC]"], "product_ndc": "51662-1514", "generic_name": "ONDANSETRON", "labeler_name": "HF Acquisition Co LLC, DBA HealthFirst", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "ONDANSETRON", "active_ingredients": [{"name": "ONDANSETRON", "strength": "4 mg/1"}], "application_number": "ANDA090469", "marketing_category": "ANDA", "marketing_start_date": "20200331", "listing_expiration_date": "20261231"}